Literature DB >> 23129291

Organic delirious states and other psychiatric disorders: lessons for the hepatologists.

Raben Rosenberg1, Signe Groth Renvillard, Simon Hjerrild.   

Abstract

Hepatic encephalopathy (HE) is characterized by a wide variety of neuropsychiatric symptoms, and from a psychiatric perspective its nosological status calls for clarification. According to the ICD-10 classification, it can be classified as delirium due to overt HE's core symptom of clouding of consciousness in increasing degrees. Minimal/covert HE with impairment of neurocognitive function is more difficult to classify and could correspond to Mild Cognitive Impairment or mild degrees of dementia. However, the advantages of current psychiatric nosology is the possibility of thorough characterization of both dispositional and premorbid psychopathology as well as psychiatric morbidity induced by liverdiseases or even treatment. A future closer collaboration between hepatologists and psychiatrists is advocated.

Entities:  

Mesh:

Year:  2012        PMID: 23129291     DOI: 10.1007/s11011-012-9340-8

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  9 in total

Review 1.  Neuropsychological characterization of hepatic encephalopathy.

Authors:  K Weissenborn; J C Ennen; H Schomerus; N Rückert; H Hecker
Journal:  J Hepatol       Date:  2001-05       Impact factor: 25.083

2.  Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Reisa A Sperling; Paul S Aisen; Laurel A Beckett; David A Bennett; Suzanne Craft; Anne M Fagan; Takeshi Iwatsubo; Clifford R Jack; Jeffrey Kaye; Thomas J Montine; Denise C Park; Eric M Reiman; Christopher C Rowe; Eric Siemers; Yaakov Stern; Kristine Yaffe; Maria C Carrillo; Bill Thies; Marcelle Morrison-Bogorad; Molly V Wagster; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

Review 3.  Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy.

Authors:  Juan Francisco Rivera Ramos; Celina Rodríguez Leal
Journal:  Ann Hepatol       Date:  2011-06       Impact factor: 2.400

Review 4.  New assessment of hepatic encephalopathy.

Authors:  Juan Córdoba
Journal:  J Hepatol       Date:  2010-12-05       Impact factor: 25.083

Review 5.  Covert hepatic encephalopathy: not as minimal as you might think.

Authors:  Matthew R Kappus; Jasmohan S Bajaj
Journal:  Clin Gastroenterol Hepatol       Date:  2012-06-19       Impact factor: 11.382

Review 6.  Mechanisms, diagnosis and management of hepatic encephalopathy.

Authors:  Ravi Prakash; Kevin D Mullen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-08-10       Impact factor: 46.802

7.  Depression, fatigue, and functional disability in patients with chronic hepatitis C.

Authors:  M M Dwight; K V Kowdley; J E Russo; P S Ciechanowski; A M Larson; W J Katon
Journal:  J Psychosom Res       Date:  2000-11       Impact factor: 3.006

8.  Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects.

Authors:  Martin Schaefer; Axel Hinzpeter; Ariane Mohmand; Gesa Janssen; Maurice Pich; Markus Schwaiger; Rahul Sarkar; Astrid Friebe; Andreas Heinz; Michael Kluschke; Marlene Ziemer; Juri Gutsche; Viola Weich; Juliane Halangk; Thomas Berg
Journal:  Hepatology       Date:  2007-10       Impact factor: 17.425

Review 9.  Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines.

Authors:  Christopher Randolph; Robin Hilsabeck; Ainobu Kato; Parampreet Kharbanda; Yu-Yuan Li; Daniela Mapelli; Lisa D Ravdin; Manuel Romero-Gomez; Andrea Stracciari; Karin Weissenborn
Journal:  Liver Int       Date:  2009-03-19       Impact factor: 5.828

  9 in total
  3 in total

1.  The confusion assessment method for the intensive care unit in patients with cirrhosis.

Authors:  Eric S Orman; Anthony Perkins; Marwan Ghabril; Babar A Khan; Naga Chalasani; Malaz A Boustani
Journal:  Metab Brain Dis       Date:  2015-05-07       Impact factor: 3.584

2.  Altered cortical brain activity in end stage liver disease assessed by multi-channel near-infrared spectroscopy: Associations with delirium.

Authors:  Atsushi Yoshimura; Carrie Goodson; Jordan T Johns; Maxwell M Towe; Esme S Irvine; Nada A Rendradjaja; Laura K Max; Andrew LaFlam; Emily C Ledford; Julia Probert; Zoë Tieges; David H Edwin; Alasdair M J MacLullich; Charles W Hogue; Martin A Lindquist; Ahmet Gurakar; Karin J Neufeld; Atsushi Kamiya
Journal:  Sci Rep       Date:  2017-08-23       Impact factor: 4.379

3.  Overt Hepatic Encephalopathy Experienced by Individuals With Cirrhosis: A Qualitative Interview Study.

Authors:  Lea Ladegaard Grønkjær; Thomas Hoppe Sehstedt; Annelise Norlyk; Hendrik Vilstrup
Journal:  Gastroenterol Nurs       Date:  2018 Nov/Dec       Impact factor: 0.978

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.